Clinical Trial Update: REcanalization of Distal Cerebral Vessels in Acute Stroke Using ApeRio®

View source ↗

Summary

Completed clinical trial evaluating recanalization of distal cerebral vessels in acute stroke using ApeRio by Acandis GmbH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• ApeRio

Snippet

Sponsor: Acandis GmbH | Conditions: Acute Stroke | Status: COMPLETED